Inspire Medical Systems, Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
8
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
INSP
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $72.25 (+27.4%)
12 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
INSP
JNJ
11.6×
Trailing P/E
26.3×
21.9×
Forward P/E
17.9×
15.9%
Profit Margin
21.8%
85.4%
Gross Margin
68.0%
19.8%
ROE
26.4%
12.2%
Revenue Growth
9.9%
308.4%
Earnings Growth
-52.9%
0.86
Beta
0.33
—
Price / Book
—
$1.6B
Market Cap
$546.9B
$48 – $163
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →